New research indicates that patients who come off popular weight-loss injections like semaglutide or tirzepatide tend to recover shed pounds far faster than those who stop conventional diet and exercise plans.
Research printed in a prominent medical journal shows that while obese people often shed substantial amounts of their total mass while undergoing treatment, the mass is regained at an average rate of nearly a kilo each month upon discontinuation.
"Individuals using such medications need to be informed of the danger of fast rebound weight gain when the medication ends," cautioned expert Dr. Susan Jebb.
That rate of recovery implies a return to original mass in about one and a half years.
Analyzing Treatments
The study, which reviewed dozens of studies involving thousands of patients, contrasted the effects of GLP-1 agonists with conventional dieting.
Scientists note that people who lose weight through diet and exercise typically experience a slower weight regain—around 0.1 kg a month—after stopping.
Understanding the Rapid Regain
Doctors propose the mode of action of the injections is key to understanding the accelerated rebound.
The injections mimic a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Artificially providing GLP-1 levels far above than the body's typical production might result in the system to produce less of its endogenous hormone, and could lessen responsiveness to its effects," explained Dr. Adam Collins, a nutrition expert.
"Withdrawal of this GLP-1 'fix' leads to hunger is no longer kept in check, making excessive eating far more likely."
A Chronic Condition?
The NHS suggest the jabs for people with obesity-related health risks, accompanied by prescribed lifestyle changes.
Many experts say that, considering the high risk of weight regain, the treatment might need to be long-term.
This opinion is echoed by pharmaceutical companies, who note that the results "highlight the long-term character of excess weight," comparing it to managing conditions like high blood pressure.
User Experiences
Users who have discontinued the medication describe a intense resurgence of cravings.
"I experienced a trigger that goes on and you're instantly starving," described a patient.
The struggle is worsened if users have not adopted permanent lifestyle or habit changes during therapy.
Growing Adoption
Survey data show that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with demand being substantial.
- Adoption is greater among females compared to men.
- The middle-aged age group shows the highest level of interest.
- A large proportion obtain the drugs through private healthcare rather than the NHS.
In conclusion, experts stress that while these medications are potent agents for shedding pounds, they are not a magic fix and maintained weight loss likely depends on integrated lifestyle support.
